ZombieHealthcare
What Happened to Coeptis Therapeutics Holdings?
Ticker: COEPSPAC Year: 2020
Return
+10.6%
Current Price
$1
Peak Price
$428.4
Trust Size
$16M
Summary
Co-Diagnostics develops molecular diagnostics products, including PCR-based tests for infectious diseases, using its proprietary CoPrimer technology platform.
What Happened
Co-Diagnostics gained prominence during the COVID-19 pandemic for its PCR testing technology. The company went public and has been developing non-COVID diagnostic products using its CoPrimer platform, which offers improved accuracy over standard PCR. However, as pandemic testing demand waned, revenue declined sharply, leading to going concern warnings.
Timeline
2020-10-13
S-1 Registration Filed